Imre Berger

Title: Imre Berger: Innovator in Adenoviral Delivery Systems

Introduction

Imre Berger is a distinguished inventor based in Clifton, GB, known for his significant contributions to the field of biotechnology. He holds three patents that focus on innovative adenoviral coat protein-derived delivery vehicles. His work has the potential to revolutionize how therapeutic agents are delivered within the body.

Latest Patents

Berger's latest patents include advancements in adenoviral coat protein-based delivery vehicles. The first patent describes new adenoviral coat protein-based delivery vehicles that utilize modified penton base protomers to assemble into virus-like particles (VLPs). These VLPs can be engineered to specifically bind to various targets and can carry additional cargo such as drugs, proteins, or nucleic acids. The second patent focuses on an engineered adenovirus penton base protomer that includes multiple RGD-loops and a variable loop, allowing for the incorporation of non-adenoviral antigenic polypeptides. This innovation enhances the capability of the engineered protomer to assemble into VLPs.

Career Highlights

Imre Berger has worked with prestigious organizations such as the European Molecular Biology Laboratory and the Centre National de la Recherche Scientifique. His experience in these institutions has contributed to his expertise in molecular biology and biotechnology.

Collaborations

Throughout his career, Berger has collaborated with notable colleagues, including Frédéric Garzoni and Pascal Fender. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

Imre Berger's work in adenoviral delivery systems exemplifies the intersection of innovation and biotechnology. His patents and career achievements highlight his role as a leading inventor in this critical area of research.